TY - JOUR T1 - Molecular Imaging Biomarkers for Oncology Clinical Trials JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 525 LP - 528 DO - 10.2967/jnumed.113.126128 VL - 55 IS - 4 AU - David A. Mankoff AU - Daniel A. Pryma AU - Amy S. Clark Y1 - 2014/04/01 UR - http://jnm.snmjournals.org/content/55/4/525.abstract N2 - Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This “Focus on Molecular Imaging” article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging. ER -